Note: All prices and reports are based on end of the day (EOD) data.
AstraZeneca Pharma India Limited (ASTRAZEN)
What ASTRAZEN does

AstraZeneca Pharma India Limited

What company does?Pharmaceutical research, development, and marketing
Established1979
Entity typePrivate
HeadquartersIndia
SegmentB2B,B2C
AstraZeneca Pharma India Limited is a share market listed company in the Pharmaceuticals industry . It got listed on NSE on 04-MAY-2001 under the trading symbol ASTRAZEN. On BSE it is listed under trading symbol ASTRAZEN. The company operates in Pharmaceutical , Healthcare and Biotechnology categories.

Company overview

AstraZeneca Pharma India Limited is a subsidiary of the global biopharmaceutical company AstraZeneca, which has been operating in India for over 40 years. The company focuses on discovering, developing, manufacturing and marketing prescription medicines that improve and extend people’s lives.

The company's product portfolio spans across several therapeutic areas including oncology, cardiovascular, respiratory, inflammation and autoimmune diseases. Some of its well-known drugs include Osimertinib (Tagrisso) for non-small cell lung cancer, Durvalumab (Imfinzi) for advanced bladder cancer, and Ibrutinib (Imbruvica) for chronic lymphocytic leukemia.

One aspect that sets AstraZeneca apart from its competitors is its commitment to innovation. The company invests heavily in research and development with an aim to bring forth groundbreaking treatments that address unmet medical needs. It leverages innovative technologies such as genomics, big data analytics and artificial intelligence to drive drug discovery and development processes.

In addition to its focus on cutting-edge science and medicine, AstraZeneca also stands out due to its dedication to sustainability initiatives aimed at reducing environmental impact throughout their operations. This includes efforts towards carbon neutrality across their entire value chain by 2025.

A notable collaboration worth mentioning is the partnership between AstraZeneca Pharma India Limited and the Indian government's Department of Biotechnology where they have jointly established a Centre of Excellence focused on researching potential COVID-19 vaccines as part of India's fight against the pandemic.

Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.